BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23527290)

  • 1. Preliminary characterisation of tumor necrosis factor alpha and interleukin-10 responses to Chlamydia pecorum infection in the koala (Phascolarctos cinereus).
    Mathew M; Beagley KW; Timms P; Polkinghorne A
    PLoS One; 2013; 8(3):e59958. PubMed ID: 23527290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 17A is an immune marker for chlamydial disease severity and pathogenesis in the koala (Phascolarctos cinereus).
    Mathew M; Waugh C; Beagley KW; Timms P; Polkinghorne A
    Dev Comp Immunol; 2014 Oct; 46(2):423-9. PubMed ID: 24915607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic diversity of Chlamydia pecorum strains in wild koala locations across Australia and the implications for a recombinant C. pecorum major outer membrane protein based vaccine.
    Kollipara A; Polkinghorne A; Wan C; Kanyoka P; Hanger J; Loader J; Callaghan J; Bell A; Ellis W; Fitzgibbon S; Melzer A; Beagley K; Timms P
    Vet Microbiol; 2013 Dec; 167(3-4):513-22. PubMed ID: 24012135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterisation and expression analysis of interferon gamma in response to natural Chlamydia infection in the koala, Phascolarctos cinereus.
    Mathew M; Pavasovic A; Prentis PJ; Beagley KW; Timms P; Polkinghorne A
    Gene; 2013 Sep; 527(2):570-7. PubMed ID: 23792018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral immune responses in koalas (Phascolarctos cinereus) either naturally infected with Chlamydia pecorum or following administration of a recombinant chlamydial major outer membrane protein vaccine.
    Khan SA; Polkinghorne A; Waugh C; Hanger J; Loader J; Beagley K; Timms P
    Vaccine; 2016 Feb; 34(6):775-82. PubMed ID: 26747718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helping koalas battle disease - Recent advances in Chlamydia and koala retrovirus (KoRV) disease understanding and treatment in koalas.
    Quigley BL; Timms P
    FEMS Microbiol Rev; 2020 Sep; 44(5):583-605. PubMed ID: 32556174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect of a Chlamydia pecorum recombinant major outer membrane protein vaccine on ocular disease in koalas (Phascolarctos cinereus).
    Nyari S; Booth R; Quigley BL; Waugh CA; Timms P
    PLoS One; 2019; 14(1):e0210245. PubMed ID: 30615687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of chlamydial infection and disease in a free-ranging koala (Phascolarctos cinereus) population.
    Nyari S; Waugh CA; Dong J; Quigley BL; Hanger J; Loader J; Polkinghorne A; Timms P
    PLoS One; 2017; 12(12):e0190114. PubMed ID: 29281731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in understanding the biology, epidemiology and control of chlamydial infections in koalas.
    Polkinghorne A; Hanger J; Timms P
    Vet Microbiol; 2013 Aug; 165(3-4):214-23. PubMed ID: 23523170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification, characterisation and expression analysis of natural killer receptor genes in Chlamydia pecorum infected koalas (Phascolarctos cinereus).
    Morris KM; Mathew M; Waugh C; Ujvari B; Timms P; Polkinghorne A; Belov K
    BMC Genomics; 2015 Oct; 16():796. PubMed ID: 26471184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Koala immunology and infectious diseases: How much can the koala bear?
    Madden D; Whaite A; Jones E; Belov K; Timms P; Polkinghorne A
    Dev Comp Immunol; 2018 May; 82():177-185. PubMed ID: 29382557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of subcutaneous versus intranasal immunization of male koalas (Phascolarctos cinereus) for induction of mucosal and systemic immunity against Chlamydia pecorum.
    Waugh CA; Timms P; Andrew D; Rawlinson G; Brumm J; Nilsson K; Beagley KW
    Vaccine; 2015 Feb; 33(7):855-60. PubMed ID: 25562793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel molecular markers of Chlamydia pecorum genetic diversity in the koala (Phascolarctos cinereus).
    Marsh J; Kollipara A; Timms P; Polkinghorne A
    BMC Microbiol; 2011 Apr; 11():77. PubMed ID: 21496349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PREVALENCE AND PATHOLOGIC FEATURES OF CHLAMYDIA PECORUM INFECTIONS IN SOUTH AUSTRALIAN KOALAS (PHASCOLARCTOS CINEREUS).
    Speight KN; Polkinghorne A; Penn R; Boardman W; Timms P; Fraser T; Johnson K; Faull R; Bate S; Woolford L
    J Wildl Dis; 2016 Apr; 52(2):301-6. PubMed ID: 26967132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumonia due to Chlamydia pecorum in a Koala (Phascolarctos cinereus).
    Mackie JT; Gillett AK; Palmieri C; Feng T; Higgins DP
    J Comp Pathol; 2016 Nov; 155(4):356-360. PubMed ID: 27567271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of Chlamydia infection on koala (Phascolarctos cinereus) semen quality.
    Hulse L; Beagley K; Larkin R; Nicolson V; Gosálvez J; Johnston S
    Theriogenology; 2021 Jun; 167():99-110. PubMed ID: 33813053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EPIDEMIOLOGY OF CHLAMYDIA-INDUCED REPRODUCTIVE DISEASE IN MALE KOALAS (
    Hulse LS; Beagley K; Ellis W; Fitzgibbon S; Gillett A; Barth B; Robbins A; Pyne M; Larkin R; Johnston SD
    J Wildl Dis; 2020 Jan; 56(1):82-92. PubMed ID: 31329524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of A Novel Picorna-Like Virus, Burpengary Virus, that is Negatively Associated with Chlamydial Disease in the Koala.
    Harvey E; Madden D; Polkinghorne A; Holmes EC
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30832350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prototype Recombinant-Protein Based Chlamydia pecorum Vaccine Results in Reduced Chlamydial Burden and Less Clinical Disease in Free-Ranging Koalas (Phascolarctos cinereus).
    Waugh C; Khan SA; Carver S; Hanger J; Loader J; Polkinghorne A; Beagley K; Timms P
    PLoS One; 2016; 11(1):e0146934. PubMed ID: 26756624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination of koalas (Phascolarctos cinereus) against Chlamydia pecorum using synthetic peptides derived from the major outer membrane protein.
    Nyari S; Khan SA; Rawlinson G; Waugh CA; Potter A; Gerdts V; Timms P
    PLoS One; 2018; 13(6):e0200112. PubMed ID: 29953523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.